NSAIDs may cause an increased risk of serious cardiovascular and gastrointestinal adverse events, which can be fatal. This risk may increase with duration of use.
Elderly patients are at greater risk for serious gastrointestinal events.
- TRADE NAMES: Ansaid (Pfizer); Apo-Flurbiprofen; Cebutid; Flurofen; Flurozin; Froben; Lapole; Nu-Flurprofen
- INDICATIONS: Rheumatoid arthritis, osteoarthritis
- CLASS: Non-steroidal anti-inflammatory (NSAID)
- HALF-LIFE: 3–4 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
ACE inhibitors, Aspirin, Furosemide, Lithium, Methotrexate
- See adverse reactions attributed to class:
CARDIOVASCULAR AND GASTROINTESTINAL RISKS
See full prescribing information for complete boxed warning
Please login to view the rest of this drug profile.
Page last updated 07/31/2023
